Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

4.23
-0.3900-8.44%
Volume:313.78K
Turnover:1.38M
Market Cap:271.81M
PE:-4.18
High:4.59
Open:4.54
Low:4.23
Close:4.62
Loading ...

Corvus publishes data on potential of soquelitinib to modulate tumor activity

TIPRANKS
·
05 Dec 2024

BRIEF-Corvus Pharmaceuticals Announces Publication Of Biochemistry And Preclinical Data

Reuters
·
05 Dec 2024

Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of Itk Inhibition With Soquelitinib as a Novel Approach to Modulate Tumor Immunity

THOMSON REUTERS
·
05 Dec 2024

Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity

GlobeNewswire
·
05 Dec 2024

Corvus Pharmaceuticals announces preclinical dataon soquelitinib

TIPRANKS
·
14 Nov 2024

Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis

GlobeNewswire
·
14 Nov 2024

An Intrinsic Calculation For Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Suggests It's 41% Undervalued

Simply Wall St.
·
14 Nov 2024

Corvus Pharmaceuticals Inc : Jefferies Raises Target Price to $13 From $8

THOMSON REUTERS
·
14 Nov 2024

Jefferies Raises Corvus Pharmaceuticals Price Target to $13 From $8, Maintains Buy Rating

MT Newswires Live
·
14 Nov 2024

Oppenheimer Adjusts Corvus Pharmaceuticals Price Target to $14 From $8, Maintains Outperform Rating

MT Newswires Live
·
13 Nov 2024

Corvus Pharmaceuticals price target raised to $24 from $21 at Ladenburg

TIPRANKS
·
13 Nov 2024

Corvus Pharmaceuticals Inc (CRVS) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid ...

GuruFocus.com
·
13 Nov 2024

Corvus Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Corvus Pharma Q3 2024 GAAP EPS $(0.60) Misses $(0.11) Estimate

Benzinga
·
13 Nov 2024

Corvus: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Corvus Pharmaceuticals options imply 17.7% move in share price post-earnings

TIPRANKS
·
13 Nov 2024